Aligos Therapeutics, Inc.
ALGSNASDAQHealthcare● Active
$4.96
+$0.05(+1.02%)
Market Cap$30693581
P/E Ratio—
52W High$13.689
52W Low$4.8
Aligos Therapeutics, Inc.（ALGS）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ALGS · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.19M | $3.94M | $15.53M | $13.91M | $4.36M |
| Cost of Revenue | $0.93M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $1.26M | $3.94M | $15.53M | $13.91M | $4.36M |
| Gross Margin %(computed) | 57.46% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $69.45M | $70.27M | $73.04M | $85.08M | $104.15M |
| G&A Expenses | $20.72M | $22.83M | $30.62M | $26.41M | $28.53M |
| Total Operating Expenses | $89.24M | $93.10M | $103.66M | $111.49M | $132.68M |
| Operating Income | ($87.98M) | ($89.15M) | ($88.13M) | ($97.58M) | ($128.32M) |
| Operating Margin %(computed) | — | — | -567.50% | -701.66% | — |
| Interest Income | $2.16M | $1.67M | $1.24M | $1.64M | $0.13M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($23.88M) | ($130.88M) | ($86.88M) | ($95.94M) | ($128.19M) |
| Income Tax Expense | $0.31M | $0.33M | $0.80M | $0.11M | $0.14M |
| Net Income | ($24.19M) | ($131.21M) | ($87.68M) | ($96.05M) | ($128.33M) |
| Net Margin %(computed) | — | — | -564.61% | -690.63% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.45 | $-20.94 | $-3.52 | $-2.25 | $-3.22 |
| Wtd Avg Shares | 9.88M | 6.26M | 24.87M | 42.70M | 39.86M |
| EBITDA | ($87.06M) | ($86.53M) | ($85.06M) | ($93.91M) | ($124.54M) |
| EBITDA Margin %(computed) | — | — | -547.74% | -675.24% | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Aligos Therapeutics, Inc.
关于Aligos Therapeutics, Inc.（ALGS）损益表
Aligos Therapeutics, Inc.（ALGS）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，ALGS实现营收$0.00B，毛利润$0.00B（毛利率57.46%），净利润($0.02B)（净利率-1106.72%）。
常见问题
ALGS · 4 问Aligos Therapeutics, Inc.（ALGS）2025财年营收为$0.00B，同比down44.6%。
ALGS revenueALGS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09